Reviewing Vicarious Surgical (NYSE:RBOT) & Envoy Medical (NASDAQ:COCH)

Envoy Medical (NASDAQ:COCHGet Free Report) and Vicarious Surgical (NYSE:RBOTGet Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Valuation and Earnings

This table compares Envoy Medical and Vicarious Surgical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Envoy Medical N/A N/A $19.23 million N/A N/A
Vicarious Surgical N/A N/A $5.16 million ($0.52) -0.77

Profitability

This table compares Envoy Medical and Vicarious Surgical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Envoy Medical N/A -45.17% 4.42%
Vicarious Surgical N/A -85.32% -65.51%

Analyst Recommendations

This is a summary of current recommendations and price targets for Envoy Medical and Vicarious Surgical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical 0 0 2 0 3.00
Vicarious Surgical 0 3 0 0 2.00

Envoy Medical presently has a consensus target price of $3.00, suggesting a potential upside of 118.60%. Vicarious Surgical has a consensus target price of $0.50, suggesting a potential upside of 24.84%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Vicarious Surgical.

Volatility & Risk

Envoy Medical has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Insider and Institutional Ownership

27.3% of Envoy Medical shares are held by institutional investors. Comparatively, 65.2% of Vicarious Surgical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Comparatively, 14.7% of Vicarious Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Envoy Medical beats Vicarious Surgical on 6 of the 8 factors compared between the two stocks.

About Envoy Medical

(Get Free Report)

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.